Baxter International Inc
(NYSE:BAX)
$
29.08
-0.1 (-0.34%)
Market Cap: 14.85 Bil
Enterprise Value: 26.69 Bil
PE Ratio: 145.40
PB Ratio: 1.89
GF Score: 74/100 Baxter International Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 12, 2021 / 05:00PM GMT
Release Date Price:
$73.86
(-0.16%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Okay. Great. So welcome to our next session here in person with the management from Baxter. We've got Jay Saccaro, EVP and CFO of the company; and Clare Trachtman, VP of IR. So Jay and Clare, thanks for making the trip. Welcome to the live stage, the first time in a couple of years, so it's very exciting, and looking forward to the conversation.
Questions & Answers
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
So let me come and sit down with you. So first, I just wanted to start with a high-level question for you, Jay, and maybe just talk about your vision for Baxter over the next few years. Without giving away the Analyst Day takeaways, could you talk at a high level about how you see the evolution of Baxter post-COVID?
James K. Saccaro
Baxter International Inc. - Executive VP & CFO
Sure, Matt. And it's
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot